Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are ...
Health Canada has approved a GLP-1 pill for the first time. The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement ...
Ottawa Citizen on MSN
Canada's Drug Agency says new Alzheimer's drug should not be publicly funded
A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results